Drugs & medicalClass II

Glenmark Pharmaceuticals Inc., USA recalls Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals Inc.,…

Failed Dissolution Specifications

Read the official notice →
Date
2023-11-15
Country
United States
Brand
Glenmark Pharmaceuticals
Product
Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ…
Classification
Class II
Units
USA nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Glenmark Pharmaceuticals recalls

  1. 2024-01-31
  2. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Fluocinolone Acetonide Oil, 0.01% (Ear Drops), package in 1 Oz. (20 mL fill volume) bottle, Rx only, Manufactured by: Glenmark…

    Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol

    FDA · DrugGlenmark Pharmaceuticals Inc., USAUSA NationwideOfficial notice →
  3. 2023-12-06
  4. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Naproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa…

    Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwideOfficial notice →
  5. 2023-11-29
  6. US
    Drugs & medicalClass III

    Glenmark Pharmaceuticals Inc., USA recalls Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle, NDC 68462-390-30; (b) 1000-count…

    Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability study (25¿C/60% RH).

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwide in the USAOfficial notice →
  7. 2023-11-15
  8. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,…

    Failed Dissolution Specifications: Out of specification for dissolution.

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwideOfficial notice →
  9. 2023-11-08
  10. US
    Drugs & medicalClass III

    Glenmark Pharmaceuticals Inc., USA recalls Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 5mg/6.25mg, 100-count Bottle, RX only, Manufactured by: Glenmark…

    Failed Impurities/Degradation Specifications

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwide in the USAOfficial notice →
  11. 2023-08-30
  12. US
    Drugs & medicalClass III

    Glenmark Pharmaceuticals Inc., USA recalls Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by:…

    Subpotent: Out of Specification for Assay Test at the 3-month time point.

    FDA · DrugGlenmark Pharmaceuticals Inc., USAnationwide in the U.S.Official notice →
All 43 Glenmark Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2023-11-15
  2. US
    Drugs & medicalClass I

    Pfizer Inc. recalls 2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx…

    Presence of Particulate Matter: identified as glass.

    FDA · DrugPfizer Inc.Nationwide in the US and Puerto Rico. The products were not distributed to…Official notice →
  3. US
    Drugs & medicalClass III

    Grato Holdings, Inc. recalls V-FORCE Homeopathic, 1 FL OZ (30 ml) per glass bottle, Distributed by: BioActive Nutritional, Inc., 1803 N. Wickham Rd., Melbourne, FL 32935

    Incorrect Product Formulation: product contains Active Ingredient Glandula Suprarenalis Suis 8X instead of Glandula Suprarenalis Bovine 8X (as stated on the product label).

    FDA · DrugGrato Holdings, Inc.Distributed to one direct account in Florida with possible further…Official notice →
  4. US
    Drugs & medicalClass II

    Zydus Pharmaceuticals (USA) Inc recalls Oxybutynin Chloride Extended-Release Tablet USP, 5 mg, 100 count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd,…

    Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide.Official notice →
  5. US
  6. US
    Drugs & medicalClass III

    VistaPharm LLC recalls Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, Manufactured for: VistaPharm, Inc., Largo, FL 33771, USA,…

    Defective Container: The adaptor does not fit into the neck of the bottle after reconstitution with water.

    FDA · DrugVistaPharm LLCNationwide and Saudi ArabiaOfficial notice →
  7. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,…

    Failed Dissolution Specifications: Out of specification for dissolution.

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwideOfficial notice →
See all drugs & medical recalls →